Werbung
Werbung

PBH

PBH logo

Prestige Consumer Healthcare Inc.

64.18
USD
Gesponsert
+0.22
+0.34%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

64.20

+0.02
+0.03%

PBH Ergebnisberichte

Positives Überraschungsverhältnis

PBH übertreffen die 31 der letzten 39Schätzungen.

79%

Nächster Bericht

Datum des nächsten Berichts
05. Feb. 2026
Estimate for Q3 26 (Revenue/ EPS)
$283.95M
/
$1.14
Implizierte Änderung von Q2 26 (Revenue/ EPS)
+3.59%
/
+6.54%
Implizierte Änderung von Q3 25 (Revenue/ EPS)
-2.19%
/
-6.56%

Prestige Consumer Healthcare Inc. earnings per share and revenue

On 06. Nov. 2025, PBH reported earnings of 1.07 USD per share (EPS) for Q2 26, beating the estimate of 0.98 USD, resulting in a 9.18% surprise. Revenue reached 274.11 million, compared to an expected 259.70 million, with a 5.55% difference. The market reacted with a +2.56% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 8 analysts forecast an EPS of 1.14 USD, with revenue projected to reach 283.95 million USD, implying an increase of 6.54% EPS, and increase of 3.59% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Neogen Corp
Report Date
08. Jan. 2026 For Q2 26
Estimate
$0.05
Aktuell
$0.10
Überraschung
+78.25%
logo
Tilray Brands, Inc. Common Stock
Report Date
08. Jan. 2026 For Q2 26
Estimate
-$0.20
Aktuell
-$0.41
Überraschung
-100.98%
FAQ
For Q2 2026, Prestige Consumer Healthcare Inc. reported EPS of $1.07, beating estimates by 9.18%, and revenue of $274.11M, 5.55% above expectations.
The stock price moved up 2.56%, changed from $59.83 before the earnings release to $61.36 the day after.
The next earning report is scheduled for 05. Feb. 2026.
Based on 8 analysts, Prestige Consumer Healthcare Inc. is expected to report EPS of $1.14 and revenue of $283.95M for Q3 2026.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung